Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C, in adults previously vaccinated with mRNA vaccine: a randomized, double-blind, placebo-controlled phase 1/2 clinical trial
Titel:
Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C, in adults previously vaccinated with mRNA vaccine: a randomized, double-blind, placebo-controlled phase 1/2 clinical trial
Auteur:
Hannawi, Suad Saf Eldin, Linda Abuquta, Alaa Alamadi, Ahmad Mahmoud, Sally A. Hassan, Aala Liu, Dongfang Yan, Lixin Xie, Liangzhi